The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens
- PMID: 8642252
- PMCID: PMC2192318
- DOI: 10.1084/jem.183.3.1105
The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens
Abstract
Mycoplasma arthritidis, an agent of chronic proliferative arthritis of rodents, secretes a potent soluble superantigen, MAM, that is active for both murine and human T and B lymphocytes. We now report the complete nucleotide and amino acid sequence of MAM and show it to be distinct from other proteins and not closely related phylogenetically to other superantigens. Two functional domains on MAM are identified based on the ability of peptides encompassing these regions to inhibit lymphocyte proliferation by the intact MAM molecule. One of these domains shares short sequences or epitopes with other microbial superantigens. The second domain contains the consensus legume lectin motif-beta, which is important for T cell activation by concanavalin (Con) A. MAM and Con A peptides containing this motif are functionally cross reactive, suggesting a novel secondary pathway for T cell activation by MAM.
Similar articles
-
The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide.Infect Immun. 1994 Dec;62(12):5367-75. doi: 10.1128/iai.62.12.5367-5375.1994. Infect Immun. 1994. PMID: 7960116 Free PMC article.
-
Immunomodulation in vivo by the Mycoplasma arthritidis superantigen, MAM.Clin Infect Dis. 1993 Aug;17 Suppl 1:S163-9. doi: 10.1093/clinids/17.supplement_1.s163. Clin Infect Dis. 1993. PMID: 8399909
-
Zinc-binding sites in the N terminus of Mycoplasma arthritidis-derived mitogen permit the dimer formation required for high affinity binding to HLA-DR and for T cell activation.J Biol Chem. 2003 Jun 20;278(25):22309-15. doi: 10.1074/jbc.M300823200. Epub 2003 Apr 3. J Biol Chem. 2003. PMID: 12676930
-
The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen.Immunol Today. 1991 Aug;12(8):271-6. doi: 10.1016/0167-5699(91)90125-D. Immunol Today. 1991. PMID: 1910449 Review.
-
Genetic control of T cell activation induced by Mycoplasma arthritidis.Isr J Med Sci. 1987 May;23(5):496-502. Isr J Med Sci. 1987. PMID: 3312095 Review.
Cited by
-
Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.Infect Immun. 1997 Oct;65(10):4190-8. doi: 10.1128/iai.65.10.4190-4198.1997. Infect Immun. 1997. PMID: 9317026 Free PMC article.
-
Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA-DR1 reveals a novel superantigen fold and a dimerized superantigen-MHC complex.Structure. 2004 Feb;12(2):277-88. doi: 10.1016/j.str.2004.01.008. Structure. 2004. PMID: 14962388 Free PMC article.
-
Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor.J Exp Med. 1998 Feb 2;187(3):319-27. doi: 10.1084/jem.187.3.319. J Exp Med. 1998. PMID: 9449712 Free PMC article.
-
Crystallization and preliminary crystallographic analysis of Mycoplasma arthritidis-derived mitogen complexed with peptide/MHC class II antigen.Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):353-6. doi: 10.1107/S090744490302763X. Epub 2004 Jan 23. Acta Crystallogr D Biol Crystallogr. 2004. PMID: 14747723 Free PMC article.
-
Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, on bone resorption in vitro.Infect Immun. 1999 Dec;67(12):6281-5. doi: 10.1128/IAI.67.12.6281-6285.1999. Infect Immun. 1999. PMID: 10569738 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases